Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Operating Income

Latest operating income for IQMDU: $4.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-3750582.00

As of Dec 31, 2022

Annual Operating Income (TTM)

$4366.13B

Trailing 12 months ending Dec 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) FAQ

The latest operating income for IQMDU is $4.4T as of December 2022. Investors often review this figure alongside Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

A operating income figure of $4.4T for IQMDU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IQMDU's operating income ($4.4T), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.